Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06601829

Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital

polycystic kidney disease is aherditary disorder characterized by the formation of numerous fluid filled cysts in the kidneys which can lead to progressive renal impairment PKDencompasses aspectrum of disorders with autosomal dominant polycystic kidneydisease and autosomal recessive polycystic kidney disease being the two main types

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital Hepatic Fibrosis, Congenital

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag university Hospital

Sohag, Egypt

Location status: Recruiting

Location contact

Magdy m amin, professor

CONTACT

[email protected]

0934602963

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pediatric patients aged 0-18 years both male and female patients

Exclusion criteria

  • patients whose guardians dont provide informed consent patients who are not complient with follow up vists and data collection protocols

Treatment and study plan

Abdominal ultrasound

Other

abdominal ulterasound showing multiple cysts in the kidnets and hepatic fibrosis

Primary outcomes

  1. incidence of congenital hepatic fibrosis in patient with autosomal recessive polycyctic kidney disease

    Time frame: 12 months

    describe congenital hepatic fibrosis in patient with autosomal recessive polycystic kidney explaining their clinical manifestations.diagnosis.managment and complications

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Sep 19, 2024
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.